Glidian Joins Infinx to Advance Prior Authorization Automation and Expand Market Reach

Infinx, a leader in AI-powered profits cycle monitoring options, introduces the purchase of Glidian, a market leader in previous permission automation. The critical action reinforces Infinx’s individual gain access to options while increasing its impact busy market, where Glidian has actually developed itself as a leader.

Glidian was started with the objective of automating previous permissions to make certain clients get prompt accessibility to medical care. By integrating innovation and solutions, Glidian has actually accomplished thorough market protection. Infinx shares this vision, making the purchase an all-natural suitable for both firms.

” This collaboration is an interesting advance for both companies,” claimed Jaideep Tandon, Chief Executive Officer at Infinx. “Glidian’s know-how in previous permission innovation, especially within the research laboratory area, enhances Infinx’s durable collection of individual gain access to options. We’re delighted to invite the Glidian group to the Infinx household and eagerly anticipate proceeding our ruthless development to resolve the discomfort factors in individual gain access to and previous permission. With each other, we will certainly provide also higher worth to doctor and their clients.”

The choice to incorporate Glidian right into Infinx comes with a turning point. Both firms have actually constructed combinations with a number of across the country payers, and by combining these links, they will certainly improve effectiveness and improve operations for clients. With each other, Infinx and Glidian currently refine approximately 700,000 individual gain access to purchases monthly, strengthening their setting as a giant in individual gain access to automation.

By leveraging Infinx’s innovative AI abilities, Glidian clients will certainly gain from improved automation, boosted precision, and sped up prior permission approvals. Infinx’s AI-driven system continually discovers and adjusts to payer demands, decreasing management worry and assisting medical care companies enhance their operations. The mix of AI-powered knowledge with Glidian’s well-known options will certainly offer clients with a smooth, a lot more effective previous permission procedure.

” Infinx’s dedication to development and client success makes them the excellent companion for Glidian,” claimed Ashish Dua, Chief Executive Officer at Glidian. “With Infinx’s sources and know-how, we can better speed up previous permission automation and increase our item offerings, eventually enhancing the individual gain access to experience for all.”

To learn more on previous permission options, seeinfinx.com/prior-authorization-solution To find out more regarding the Infinx Agentic System, see infinx.com/revenue-cycle-agent-platform.

Concerning Infinx

Established In 2012, Infinx offers scalable, AI-driven options to enhance the monetary lifecycle of doctor throughout all features of individual gain access to and profits cycle monitoring. Our cloud-based software program, powered by AI and automation, is leveraged by seasoned professionals and invoicing professionals throughout the united state, India, and the Philippines. We assist 172,000 medical care specialists throughout 4,000 centers catch even more profits, remain in advance of transforming guidelines and payer standards, and concentrate on individual treatment. To learn more, see infinx.com.

Concerning Glidian

Glidian is a leading company of previous permission automation options for the research laboratory area, committed to streamlining the medical care permission procedure. With combinations throughout countless payors, Glidian procedures over one million permissions each year, offering greater than 92,000 suppliers across the country. By leveraging innovative innovation and a group of previous permission professionals, Glidian improves profits capture, boosts functional performance, and speeds up individual treatment.

Initially revealed March 17th, 2025